Qfrjnygmrcu8q7c1fku6

Group B Strep (GBS) Online Course

Evidence-based course to help you feel more confident about Group B Strep. Includes clinical guidelines for UK, USA, CANADA, AUSTRALIA & NZ. Up to 11 CE credits

  Enroll in Course


LIMITED TIME SPECIAL OFFER

"YOU CHOOSE WHAT YOU CAN AFFORD TO PAY"

Ends Friday 25th January at 23.59 (USA Pacific)

We believe every health professional needs to be fully up-to-speed with the latest evidence-based research about group B Strep. This knowledge can save lives.

We understand it's the beginning of the year and budgets might be tight.

We want to make this critical information accessible and affordable by every health professional.

Until Friday 25th Jan, we're giving you the chance to choose what you pay for this course - remember it's been approved for up to 11 CE credits.

  • 10.5 CERPS approved by IBLCE
  • 11 LAMAZE CONTACT HOURS approved by LAMAZE INTERNATIONAL
  • 11 CONTACT HOURS accepted by ICEA
  • 1.0 CEUs / 10 HOURS by MEAC
  • 10 CPD HOURS approved by ACM
  • 10 HOURS approved by MIDWIFERY COUNCIL (NEW ZEALAND)

For example, if you are unwaged or on a low wage, or from a low income country, you can choose to pay less. If you can afford to pay more, you can choose a higher price option.

This "Choose What You Pay" special offer ends on Friday 25th January at 23.59 (USA Pacific Time). Then the price will return to the Usual Price of USD $247.

Get started now!



“As a home birth midwife, I found this course very helpful. It was very well presented, and I plan to update my informed choice about GBS and it's risks with some new information I learned.”

- Karen, Home Birth Midwife, Wisconsin, USA

"I wanted to comment on the quality of this course. I found it fantastic - very educational for me, and hopefully others. I prefer more accessible materials in comparison to long pedantic manuscripts so I really enjoyed the way that information was presented.

- Lauren, Medical Student, Canada

"A thorough, convenient course that will help me educate my birth doula clients so they can make the best decisions for their own health and that of their babies."

- Susan, Birth Doula, San Francisco, USA

"Another amazing course from Toni and the Microbirth Team. I come away from each course motivated and inspired and mostly grateful for such interesting, relevant, and up to date information that I can share with my clients in an easy to understand way. Look forward to the next one!"

- Michelle, Birth Doula, Japan

 

Group B Strep (GBS) Online Course


Accredited Continuing Education

from 5 leading group B Strep experts


VICTOR NIZET: Professor & Vice Chair for Basic Research, Department of Pediatrics & Chief, Division of Host-Microbe Systems & Therapeutics. And Professor, Skaggs School of Pharmacy & Pharmaceutical Sciences, University of California San Diego

MEGHAN AZAD: Assistant Professor of Pediatrics and Child Health at the University of Manitoba, Canada. Dr. Azad serves on the Executive Council for the International Society for Research in Human Milk and Lactation, and the Breastfeeding Committee of Canada.

ANITA KOZYRSKYJ: Professor in the Department of Pediatrics, University of Alberta, Canada. Dr Kozryskyj is the PI of SyMBIOTA (Synergy in Microbiota) research program, one of the seven CIHR-funded Canadian Microbiome Initiative teams

PHILIP STEER: Emeritus Professor of Obstetrics, Imperial College London. Dr Steer has authored 135 research papers, and many reviews, editorials and book chapters/books. Former Editor-in-Chief of BJOG – an International Journal of Obstetrics and Gynaecology, he is the current Chair of the GBS Support medical advisory panel.

JANE PLUMB MBE: Chief Executive, Group B Strep Support. A former member of the Department of Health priority setting workshops for GBS research and current member of the International Symposium on Streptococcus Agalactiae Disease scientific committee. Co-vice chair of the Royal College of Obstetricians & Gynaecologists’ Women’s Network.


If you are a health professional, ask yourself.....

- Do you feel 100% confident about group B Strep?

- Do you fully understand the current clinical guidelines?

- Are you up-to-date with the latest evidence-based research?



GROUP B STREP (GBS) ONLINE COURSE:

Helping YOU feel more confident about group B Strep.

Helping YOU support parents with full informed choice.


Evidence-based with up-to-date references


Easy-to-understand & easy-to-digest


Go-at-your-own pace with no deadlines


Learn from 5 world-leading professors and experts


Approved for up to 11 CE credits


Downloadable handouts & Certificate of Completion



Remember, this information can save lives.

Group B Strep is the leading cause

of serious infection in newborn babies.


A positive CAMP test proving group B Streptococcus is present. (By Blueiridum CC0)


Approved Continuing Education for midwives, doulas, childbirth educators and lactation consultants.

10 CPD HOURS approved by the Australian College of Midwives (ACM)

10 HOURS approved by the Midwifery Council (New Zealand) Alto Films Ltd Approval Number: 2018CME038E

10 HOURS or 1.0 CEU approved by the Midwifery Education Accreditation Council (MEAC) MEAC ID #M1819-02-0910DE

11.0 LAMAZE CONTACT HOURS approved by Lamaze International #LIN 18-14

11.0 CONTACT HOURS accepted by The International Childbirth Education Association (ICEA) #LIN 18-14

10.5 CERPS (9.5 R-CERPs & 1 L-CERP) approved by the International Board of Lactation Consultants Examiners (IBLCE) CERPs Registry Number #318043K






 
Course Content covers:
  • šGroup B Strep and the human microbiome – including the microbial properties and the special virulence factors of GBS (learn what they are in the course!)

  • Group B Strep and vaginal birth, C-section and preterm birth
  • šExplanation of ‘Universal Screening’ and ‘Risk-based’ approaches to prevent GBS infections
  • šLatest research on maternal IV antibiotics for GBS and the potential impact on the infant microbiome
  • šLatest research on breastfeeding and group B Strep
  • šLatest developments about a potential maternal GBS vaccine
  • šClinical guidelines to prevent GBS infections for USA, Canada, Australia, New Zealand and UK

Evidence-based visual presentations

combined with HD short videos

  • For example, from Session 2 on group B Strep in newborns:

Class Curriculum


  PART TWO: GUIDELINES FOR UK, USA, CANADA, AUSTRALIA AND NEW ZEALAND
Available in days
days after you enroll

 
Course Format

The course format is a mixture of evidence-based visual presentations, short videos, graded tests, discussion forums, evaluations and downloadable handouts.

11 hours of course content delivered in short easy-to-undertand bite-sized learning sessions.


There's no deadline to complete the course so you can go-at-your-own pace


Each session includes picture and text-based PDF's, full HD short videos, discussion forums and quizzes


Full set of downloadable handouts including printable Certificate of Completion (with approved CE credits)


LIMITED TIME SPECIAL OFFER

"YOU CHOOSE WHAT YOU CAN AFFORD TO PAY"

Ends on 25th January at 23.59 (USA Pacific)

We want to make this critical information accessible and affordable by every health professional.

So for this week only, we're giving you the chance to choose what you pay for this course - remember it's been approved for up to 11 CE credits.

    • 10.5 CERPS approved by IBLCE
    • 11 LAMAZE CONTACT HOURS approved by LAMAZE INTERNATIONAL
    • 11 CONTACT HOURS accepted by ICEA
    • 1.0 CEUs / 10 HOURS by MEAC
    • 10 CPD HOURS approved by ACM
    • 10 HOURS approved by MIDWIFERY COUNCIL (NEW ZEALAND)

For example, if you are unwaged or on a low wage, or from a low income country, you can choose to pay less.

If you can afford to pay more, you can choose a higher price option.

Get started now!



FEATURED SPEAKERS


Philip Steer, Emeritus Professor of Obstetrics and Gynaecology, Imperial College London

Philip Steer is Professor Emeritus at Imperial College London, having been appointed Professor in 1989.

He was a consultant obstetrician for 35 years, based at the Chelsea and Westminster Hospital from 1994.

He has authored 135 research papers, and many reviews, editorials and book chapters/books. His particular interests are the pathophysiology of labour, maternal heart disease and pregnancy, and the role of GBS infection in pregnancy and labour.

He was Editor-in-Chief of BJOG – an International Journal of Obstetrics and Gynaecology - from 2005-2012, is now editor emeritus, and edits the ‘BJOG on the case’ series. He is currently an editor of ‘High Risk Pregnancy – Management Options’ with the fifth edition published by Cambridge University Press in 2017. He was President of the British Association of Perinatal Medicine from 1996 to 1999 and President of the Section of Obstetrics and Gynaecology of the Royal Society of Medicine from 2008 to 2009. He is an honorary member of the South African Society of Obstetricians and Gynaecologists, honorary fellow of the College of Obstetricians and Gynaecologist of South Africa, and an honorary fellow of the American Gynecological & Obstetrical Society. He has been the Chair of the GBS Support medical advisory panel since 2005

.


Professor Anita Kozyrskyj, Department of Pediatrics, University of Alberta

Dr Kozyrskyj's epidemiological research uses population-based birth cohort studies with linkage to existing healthcare databases. Her research interests focus on early life programming of childhood atopic disease and overweight, as influenced by birth method, infant diet and antibiotic use during pregnancy, birth and infancy.

Dr Kozryskyj is the PI of SyMBIOTA (Synergy in Microbiota) research program, one of the seven CIHR-funded Canadian Microbiome Initiative teams. The SyMBIOTA program, which derives its data from the 4-site CHILD (Canadian Healthy Infant Longitudinal Development) pregnancy cohort study, aims to investigate influences on infant gut microbiota and the connection to the development of atopy and overweight.


Meghan Azad, Assist. Professor, Department of Pediatrics & Child Health, University of Manitoba

Assistant Professor, Department of Pediatrics & Child Health and Community Health Sciences, University of Manitoba; Associate Investigator, Canadian Healthy Infant Longitudinal Development (CHILD) Study, Research Scientist, Children’s Hospital Research Institute of Manitoba; co-Lead, Population Health Pillar, Developmental Origins of Chronic Diseases in Children Network (DEVOTION).

Dr Azad’s research focuses on the developmental origins of health and disease (DOHaD). Increasingly, early-life exposures are being linked to the development of non-communicable diseases throughout the life course. Perinatal exposures including parent lifestyle and diet, environmental chemicals, nutrition and the social environment have been identified as early determinants of chronic disorders including allergies, asthma, obesity, and cardiovascular disease. DOHaD research addresses these complex and long-term associations, seeking a better understanding of the underlying biological mechanisms with the ultimate goal of preventing disease through intervention during critical periods of early development.


Victor Nizet, Professor of Pediatrics and Pharmacy, University of California San Diego

Victor Nizet is currently Professor and Vice Chair for Basic Research and Chief of the Division of Host-Microbe Systems & Therapeutics at the University of California, San Diego (UCSD), School of Medicine as well as Professor at UCSD Skaggs School of Pharmacy & Pharmaceutical Sciences.

Dr. Nizet is a graduate of Reed College, received his medical training at Stanford University School of Medicine, completed a Residency and Chief Residency in Pediatrics at Harvard University's Children's Hospital in Boston, Massachusetts, and a then a Fellowship in Pediatric Infectious Diseases at the University of Washington’s Children's Hospital in Seattle. Dr. Nizet leads a large basic and translational research laboratory focused on discovering virulence factors of invasive bacterial pathogens, elucidating mechanisms of host innate immunity, and novel approaches to infectious disease therapy or vaccines, with a longstanding interest in newborn infections and group B Streptococcus (GBS). Dr. Nizet has authored over 410 peer-reviewed publications, and has collaborated with several biotechnology interests in developing new antibiotic and immune-based therapies against drug-resistant pathogens. Dr. Nizet's work has been recognized by an American Heart Association Established Investigator Award, the American Lung Association Career Investigator Award, the American Asthma Foundation Senior Investigator Award, the E. Mead Johnson Award for Research in Pediatrics, and he been elected to the American Society for Clinical Investigation, the Association of American Physicians, and the American Academy of Microbiology.

Dr. Nizet’s laboratory offers a variety of training opportunities for graduate and medical students, clinical fellows, and junior faculty from all over the world. Details of his research program can be found on the laboratory website: http://nizetlab.ucsd.edu


Jane Plumb, Chief Executive, Group B Strep Support

Jane and husband Robert founded Group B Strep Support (GBSS) in 1996, following the death of their middle child.

GBSS is an independent UK charity with a highly-respected and independent medical advisory panel working to stop group B Strep infection in babies. The charity provides information and support to families affected by group B Strep and their health professionals, and supports relevant research. Jane has worked with many UK medical bodies, contributing to group B Strep related consultations, was a member of the UK National Screening Committee’s Antenatal Care GBS subgroup, the HTA’s GBS Protocol Development Group, the committees for NICE’s guideline and quality standard for Antibiotics for Neonatal Infection, and for their guideline and quality standard for Preterm Labour and Preterm Birth.

She has worked on a number of research projects as co-applicant providing PPI support, including DeVANI, HTA and other research. She was a member of the Department of Health priority setting workshops for GBS research and is a member of the International Symposium on Streptococcus Agalactiae Disease scientific committee.

She is co-vice chair of the Royal College of Obstetricians & Gynaecologists’ Women’s Network, and regularly speaks at conferences and events about group B Strep in the UK and internationally. Jane was awarded an MBE for services to Child Healthcare in 2012.


Why are we doing this?

Here’s an outline of our goals for our Group B Strep (GBS) Online Course.

  • Group B Strep (GBS) is a complex, nuanced and difficult subject that can cause much confusion for many health professionals. Current clinical guidelines to prevent GBS infections can be a minefield to navigate. This means Group B Strep can be a conversation stopper, because many health professionals do not feel fully confident on the subject.

  • Our Group B Strep (GBS) Online Couse sets out to explain in an easy-to-understand way the latest thinking on group B Strep, including an explanation of the latest evidence-based research, the current guidelines and practices in the UK, USA, Canada, Australia and New Zealand, and possible future developments to prevent group B Strep infections in newborns.

  • The Group B Strep (GBS) Online Course is designed to help health professionals feel much more confident on this difficult subject, so they can be in a better position to empower parents with full informed choice. Our hope is that this course provides a platform for debate and discussion about whether current guidelines and practices need to be reviewed. We also hope the course will highlight the urgent need for much more research to help improve health outcomes for all mums and babies.

Your Instructor


Toni Harman
Toni Harman

Toni Harman is the co-producer/director of the of the multi award-winning documentary MICROBIRTH and co-author of the books, THE MICROBIOME EFFECT (UK & World) & YOUR BABY'S MICROBIOME (US/Canada). Toni is the creator and course leader of MICROBIRTH ONLINE COURSE.

Toni has been featured as a guest on BBC Radio 4 Woman's Hour, BBC Radio 5 Live, BBC World Service and also she has appeared as a guest on numerous podcasts. Her work has been featured in The Observer, The Daily Telegraph and the Daily Mail. Toni has written blog-post articles for Scientific American and the Huffington Post. Toni has also been keynote speaker at several international scientific, midwifery and breastfeeding conferences.

You can contact Toni Harman via the contact form HERE.


Continuing Education

This program has been approved for 10 CPD HOURS by the Australian College of Midwives (ACM)

This program has been approved by Lamaze International for 11.0 Lamaze Contact Hours (LIN 18-14). These hours may be applied towards recertification as an LCCE educator under the learning competencies 3 and 5.

This program is accepted by The International Childbirth Education Association (ICEA) for 11.0 Contact Hours

This program has been approved for 9.5 R-CERPs & 1 L-CERP by International Board of Lactation Consultants Examiners (IBLCE) CERPs Registry Number #318043K

This event is approved as continuing midwifery education for 10 Hours by the Midwifery Council (New Zealand.) Alto Films Ltd Approval Number: 2018CME038E

This program has been approved for 10 Hours or 1.0 CEU by the Midwifery Education Accreditation Council (MEAC) MEAC ID # M1819-02-0910DE

On completion of the course, a Certificate of Completion will automatically be generated (see below), or you can choose to download one of the other certificates with CE credits.



Additional Continuing Education Information

- 10.5 CERPs (1 L-CERP and 9.5 R-CERPs) can be used for recertification for Lactation Consultants (IBCLC). Five years after most recently passing the IBLCE certification exam, IBCLCs may renew their certification by demonstrating completion of 75 hours of continuing education that has been approved for CERPs. Of these, at least 50 must be L-CERPs. IBCLCs recertifying by CERPs may use up to 20 R-CERPs to complete recertification requirements.

- This course is an Australian College of Midwives CPD Recognised Activity and has been approved for 9 CPD Hours. Australian Midwives and Nurses are required to collect 20 hours of Continuing Professional Development (CPD) each year, so this course will provide 9 CPD Hours out of those 20 CPD Hours. If required for auditing, the course certificate will provide date and number of CPD Hours. If required for auditing, a brief description of objectives are listed at the start of each course session.

Get started now!



Frequently Asked Questions


When does the course start and finish?
The course starts now and never ends! It is a completely self-paced online course - you decide when you start and when you finish.
How long do I have access to the course?
How does lifetime access sound? After enrolling, you have unlimited access to this course for as long as you like - across any and all devices you own.
What if I am unhappy with the course?
We would never want you to be unhappy! If you are unsatisfied with your purchase, contact us in the first 30 days and we will give you a full refund. You can contact us via the CONTACT US page on the Microbirth website: http://microbirth.com/contact-us/